Clinical and Safety Outcomes of Semaglutide by CKD Severity in the FLOW trial

Clinical and Safety Outcomes of Semaglutide by CKD Severity in the FLOW trial
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than January 23, 2025. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/56c2bc765ba6e2ec7beef59f47f805d8.pdf
Katherine
Tuttle
15
Mustafa Arici marici@hacettepe.edu.tr Hacettepe University Faculty of Medicine Ankara Türkiye
Ecenur Guder Arslan eeua@novonordisk.com Novo Nordisk A/S Global Medical Affairs Soborg Denmark
Srikanth Bellary s.bellary@aston.ac.uk Aston University Diabetes and Endocrinology Birmingham United Kingdom
Thomas Idorn thid@novonordisk.com Novo Nordisk A/S Clinical Drug Development Soborg Denmark
Linong Ji jiln@bjmu.edu.cn Peking University People's Hospital Endocrinology and Metabolism Beijing China
Zdravko Kamenov zkamenov@hotmail.com Alexandrovska University Hospital Endocrinology Sofia Bulgaria
Naoki Kashihara kashinao@med.kawasaki-m.ac.jp Kawasaki Medical School Nephrology and Hypertension Kurashiki Japan
Johannes Mann johannes.mann@kms.mhn.de KfH Kidney Center Kuratorium für Dialyse und Nierentransplantation e.V Munchen Germany
Kenneth Mahaffey kmahaf@stanford.edu Stanford Center for Clinical Research, Stanford School of Medicine Medicine Palo Alto United States
Vlado Perkovic vlado.perkovic@unsw.edu.au University of New South Wales Division of VC & President Sydney Australia
Soren Rasmussen srrm@novonordisk.com Novo Nordisk A/S Biostatistics Soborg Denmark
Peter Rossing peter.rossing@regionh.dk Steno Diabetes Research Center Complications Research Herlev Denmark
Peter Andreas Schytz ppsy@novonordisk.com Novo Nordisk A/S Medical & Science Soborg Denmark
L Sreenivasamurthy drsreenivasamurthy@gmail.com Lifecare Hospital and Research Centre Internal Medicine (Diabetology) Bangalore India
Richard Pratley richard.pratley.md@adventhealth.com AdventHealth Translational Research Institute Diabetes Orlando United States